The present invention relates to medicine and biotechnology and can be used in the pharmaceutical industry. The proposed technical solution is a method of separating and purifying imiglucerase, which is used in long-term enzyme-replacement therapy in patients who have a diagnosis of Gaucher' s disease. The proposed purification method comprises an imiglucerase deglycosylation step that is performed in a single step using a mix of enzymes.